The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)

作者: Timothy J. Bell , Sunil J. Panchal , Christine Miaskowski , Susan C. Bolge , Tsveta Milanova

DOI: 10.1111/J.1526-4637.2008.00495.X

关键词:

摘要: Objective.  This multinational, Internet-based survey was designed to assess the prevalence, frequency, severity, and impact of opioid-induced bowel dysfunction (OBD) in patients receiving opioid therapy for chronic pain taking laxatives. Design.  In total, 322 daily oral opioids laxatives completed 45-item questionnaire. At time survey, 45% reported <3 movements per week. The most prevalent side effects were constipation (81%) straining pass a movement (58%). Those considered bothersome by (in order rank) constipation, straining, fatigue, small or hard movements, insomnia. Results.  Most OBD symptoms specified questionnaire experienced majority ≥4 times Constipation symptom that often as severe. their had at least moderate negative on overall quality life activities living. A third missed, decreased stopped using make it easier have movement. Conclusion.  findings confirm occurs frequently, despite use laxatives, individuals pain. These gastrointestinal add burden already patients, negatively impacting and, some cases, affecting treatment itself.

参考文章(17)
Jonas Ap, Whitecar Ps, Clasen Me, Managing pain in the dying patient. American Family Physician. ,vol. 61, pp. 755- 764 ,(2000)
Peter N. Kaufman, Benjamin Krevsky, Leon S. Malmud, Alan H. Maurer, Marjorie B. Somers, Jeffrey A. Siegel, Robert S. Fisher, Role of Opiate Receptors in the Regulation of Colonic Transit Gastroenterology. ,vol. 94, pp. 1351- 1356 ,(1988) , 10.1016/0016-5085(88)90673-7
Marco Pappagallo, Incidence, Prevalence, and Management of Opioid Bowel Dysfunction American Journal of Surgery. ,vol. 182, ,(2001) , 10.1016/S0002-9610(01)00782-6
Paul Glare, J.Norelle Lickiss, Unrecognized constipation in patients with advanced cancer: A recipe for therapeutic disaster Journal of Pain and Symptom Management. ,vol. 7, pp. 369- 371 ,(1992) , 10.1016/0885-3924(92)90092-V
Cheryl Dennison, Manishi Prasad, Andrew Lloyd, Samir K Bhattacharyya, Ravinder Dhawan, Karin Coyne, The health-related quality of life and economic burden of constipation PharmacoEconomics. ,vol. 23, pp. 461- 476 ,(2005) , 10.2165/00019053-200523050-00006
David Prichard, Christine Norton, Adil E Bharucha, Management of opioid-induced constipation. Current Pain and Headache Reports. ,vol. 5, pp. 237- 240 ,(2001) , 10.1007/S11916-001-0037-7
Heidi Van Orden, Constipation: an overview of treatment Journal of Pediatric Health Care. ,vol. 18, pp. 320- 322 ,(2004) , 10.1016/J.PEDHC.2004.08.003
Sangeeta R. Mehendale, Chun-Su Yuan, Opioid-Induced Gastrointestinal Dysfunction Digestive Diseases. ,vol. 24, pp. 105- 112 ,(2006) , 10.1159/000090314
Ewan McNicol, Nathalie Horowicz-Mehler, Ruth A Fisk, Kyle Bennett, Maria Gialeli-Goudas, Priscilla W Chew, Joseph Lau, Daniel Carr, Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review The Journal of Pain. ,vol. 4, pp. 231- 256 ,(2003) , 10.1016/S1526-5900(03)00556-X
Pål Klepstad, Petter C Borchgrevink, Stein Kaasa, Effects on Cancer Patients' Health-Related Quality of Life After the Start of Morphine Therapy Journal of Pain and Symptom Management. ,vol. 20, pp. 19- 26 ,(2000) , 10.1016/S0885-3924(00)00167-6